Advanced Medical Isotope (RDGL) Stock Price, News & Analysis

Company Overview

Advanced Medical Isotope Corporation is a medical technology company developing targeted radiation products for cancer treatment. Its primary product candidate is RadioGel™, an injectable brachytherapy device designed to deliver yttrium-90 radiation directly to solid tumors. The company’s approach is intended to provide localized treatment while limiting radiation exposure to surrounding healthy tissue.

RadioGel is being developed for potential use in treating tumors that may be difficult to address with conventional external-beam radiation or surgery. The company has focused on advancing the product through research, regulatory development and clinical evaluation, although its product candidates remain subject to applicable regulatory approvals and clinical requirements.

Advanced Medical Isotope is based in the United States and has historically concentrated on the development of radioisotope-based therapies rather than operating a broad commercial healthcare services business. Publicly available information about its commercial operations, geographic reach and current leadership is limited.

Key Stats

• Today's Range: $0.04 to $0.05
• 50-Day Range: $0.04 to $0.06
• 52-Week Range: $0.04 to $0.12
• Volume: 970,617 shs
• Average Volume: 780,489 shs
• Market Capitalization: $22.72 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Advanced Medical Isotope Stock Analysis - MarketRank™

Advanced Medical Isotope scored higher than 3% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Advanced Medical Isotope.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Advanced Medical Isotope is -4.60, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Advanced Medical Isotope is -4.60, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.01% of the float of Advanced Medical Isotope has been sold short.

Short Interest Ratio / Days to Cover

Advanced Medical Isotope has a short interest ratio ("days to cover") of 0.02, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Advanced Medical Isotope has recently increased by 219.26%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Advanced Medical Isotope does not currently pay a dividend.

Dividend Growth

Advanced Medical Isotope does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

News Sentiment

Advanced Medical Isotope has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.53 average news sentiment score of Healthcare companies.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Advanced Medical Isotope insiders have not sold or bought any company stock.

Percentage Held by Insiders

18.50% of the stock of Advanced Medical Isotope is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Advanced Medical Isotope has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 3/30/2026
• Today: 10/02/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:RDGL
• CIK: 1449349
• Web: www.radiogel.com
• Phone: (509) 736-4000
• Fax: 509-736-4007
• Employees: 1
• Year Founded: 2006

Profitability

• EPS (Trailing Twelve Months): ($0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$3.07 million
• Net Margins: -3,637.37%
• Pretax Margin: -3,636.36%
• Return on Equity: N/A
• Return on Assets: -144.13%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 48.85
• Quick Ratio: 47.72

Sales & Book Value

• Annual Sales: $70 thousand
• Price / Sales: 324.60
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.02) per share
• Price / Book: -2.30

Miscellaneous

• Outstanding Shares: 493,960,000
• Free Float: 402,581,000
• Market Cap: $22.72 million
• Optionable: Not Optionable
• Beta: -0.55